FDA Orange Book · active-ingredient family
Chlorhexidine gluconate
Chlorhexidine gluconate: 16 brands, 16 generics; first approved Dec 24, 1984; generic available.
Generic availableHas discontinued products
Generic status & protection
Generic available — 16 ANDA applications approved.
Earliest patent expiry Apr 25, 2026
Brands (NDA)
16
Generics (ANDA)
16
Listed patents
2
Next patent expiry
Apr 25, 2026
3 mo ago
Originator applications
Brand (NDA) products
MEDLINE INDUSTRIESNDA 2079642018
MEDLINE INDUSTRIESNDA 2079642018
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 2% | CLOTH | TOPICAL | OTC | — |
SAGE PRODSNDA 0216692005
SAGE PRODSNDA 0216692005
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 2% | CLOTH | TOPICAL | OTC | — |
PERIOCHIPRLDDEXCEL PHARMANDA 0207741998
PERIOCHIPRLD
DEXCEL PHARMANDA 0207741998
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 2.5MG | TABLET | DENTAL | Discontinued | — |
SOLVENTUMNDA 0190281986
SOLVENTUMNDA 0190281986
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.12% | SOLUTION | DENTAL | Rx | AT |
XTTRIUMNDA 0194221985
XTTRIUMNDA 0194221985
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 2% | SOLUTION | TOPICAL | OTC | — |
XTTRIUMNDA 0191271984
XTTRIUMNDA 0191271984
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 4% | AEROSOL, METERED | TOPICAL | OTC | — |
MOLNLYCKE HLTHNDA 017768—
MOLNLYCKE HLTHNDA 017768—
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 4% | SOLUTION | TOPICAL | OTC | — |
MOLNLYCKE HLTHNDA 018300—
MOLNLYCKE HLTHNDA 018300—
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.5% | SOLUTION | TOPICAL | OTC | — |
HIBICLENSRLDMOLNLYCKE HLTHNDA 018423—
HIBICLENSRLD
MOLNLYCKE HLTHNDA 018423—
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 4% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SPONGE | TOPICAL | Discontinued | — |
BAJAJNDA 0201111997
BAJAJNDA 0201111997
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.75% | SOLUTION | TOPICAL | OTC | — |
GRIFFENNDA 0198221989
GRIFFENNDA 0198221989
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 4% | SPONGE | TOPICAL | OTC | — |
CAREFUSION 2200NDA 0197931988
CAREFUSION 2200NDA 0197931988
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 4% | SPONGE | TOPICAL | Discontinued | — |
KENDALL ILNDA 0194901987
KENDALL ILNDA 0194901987
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 4% | SPONGE | TOPICAL | Discontinued | — |
ECOLABNDA 01925819862 strengths
ECOLABNDA 01925819862 strengths
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 2% | SOLUTION | TOPICAL | OTC | — |
| 4% | SOLUTION | TOPICAL | OTC | — |
XTTRIUMNDA 0194211985
XTTRIUMNDA 0194211985
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 2.5% | SOLUTION | TOPICAL | Discontinued | — |
XTTRIUMNDA 0191251984
XTTRIUMNDA 0191251984
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 4% | SOLUTION | TOPICAL | OTC | — |
Abbreviated applications
Generic (ANDA) products (16)
COLGATE-PALMOLIVE COANDA 2032122016
COLGATE-PALMOLIVE COANDA 2032122016
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.12% | SOLUTION | DENTAL | Rx | AT |
PHARMOBEDIENTANDA 0777892009
PHARMOBEDIENTANDA 0777892009
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.12% | SOLUTION | DENTAL | Rx | AT |
SUNSTAR AMERICASANDA 0764342005
SUNSTAR AMERICASANDA 0764342005
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.12% | SOLUTION | DENTAL | Discontinued | — |
CHARTWELL RXANDA 0750062004
CHARTWELL RXANDA 0750062004
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.12% | SOLUTION | DENTAL | Rx | AT |
BAJAJANDA 0755612000
BAJAJANDA 0755612000
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.12% | SOLUTION | DENTAL | Rx | AT |
BECTON DICKINSONANDA 0734162000
BECTON DICKINSONANDA 0734162000
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 4% | SPONGE | TOPICAL | Discontinued | — |
SCIEGEN PHARMSANDA 0743561996
SCIEGEN PHARMSANDA 0743561996
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.12% | SOLUTION | DENTAL | Discontinued | — |
LYNEANDA 0742911995
LYNEANDA 0742911995
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.12% | SOLUTION | DENTAL | Rx | AT |
PHARM ASSOCANDA 0745221995
PHARM ASSOCANDA 0745221995
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.12% | SOLUTION | DENTAL | Rx | AT |
COLGATE PALMOLIVE COANDA 0736951994
COLGATE PALMOLIVE COANDA 0736951994
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.12% | SOLUTION | DENTAL | Discontinued | — |
J AND JANDA 0722921992
J AND JANDA 0722921992
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.5% | SOLUTION | TOPICAL | Discontinued | — |
J AND JANDA 0722551991
J AND JANDA 0722551991
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 4% | SOLUTION | TOPICAL | Discontinued | — |
J AND JANDA 0722951991
J AND JANDA 0722951991
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 4% | SPONGE | TOPICAL | Discontinued | — |
BECTON DICKINSONANDA 0725251989
BECTON DICKINSONANDA 0725251989
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 4% | SPONGE | TOPICAL | OTC | — |
SOAPCOANDA 0714191987
SOAPCOANDA 0714191987
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 4% | SOLUTION | TOPICAL | Discontinued | — |
MATRIX MEDCLANDA 0701041986
MATRIX MEDCLANDA 0701041986
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 4% | SOLUTION | TOPICAL | Discontinued | — |
Protection horizon
Patent & exclusivity timeline
Patent expiryExclusivity endToday
Orange Book patent file
Listed patents
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 7427574 | Apr 25, 2026 | 3 mo ago | Product |
| 7935093 | Oct 02, 2027 | in 1 yr 3 mo | ProductU-1022 |
FDA approval span
Approval history
First approval
Dec 24, 1984
42 yr 2 mo ago
Most recent approval
Nov 20, 2018
7 yr 9 mo ago
Approvals span 1984–2018 across 32 FDA applications.
Brand (NDA) 1650%
Generic (ANDA) 1650%
Chlorhexidine gluconate — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
Built directly from the FDA Orange Book data file (products, patents, and exclusivity). TE codes, RLD/RS flags, patent expirations, and exclusivity dates match the official FDA record. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Related FDA reference tools
- FDA Purple BookLicensed biologics, biosimilars, interchangeables, BLA records, and exclusivity dates.
- FDA BiosimilarsThe list of FDA-approved biosimilars and interchangeable biosimilars, by reference product.
- 510(k) Predicate DatabaseSearch FDA 510(k) clearances and map predicate-device lineage.
- FDA 483 & Inspection DatabaseFDA Form 483 observations and inspection records by firm, date, and citation.

